Innovative therapies for invasive fungal infections in preclinical and clinical development.
Yidong YuKrystyna AlbrechtJürgen GrollAndreas BeilhackPublished in: Expert opinion on investigational drugs (2020)
It is imperative to expand the pipeline of antifungals to tackle emerging fungal resistance against conventional antimycotic drugs, toxicity, and drug-drug interactions. This unmet medical need should not be underappreciated.